Global Stem Cell Market Forecast 2022-2030KEY FINDINGS
The global stem cell market is predicted to grow with a CAGR of 8.88% during the forecasted years of 2022 to 2030. The growth of the market is determined by key drivers such as the increasing demand for stem cells in regenerative medicine, the rising &D investments in stem cell therapies and research, the growing awareness about umbilical cord stem cells, and the reduced risk of tissue rejection in transplants.
MARKET INSIGHTS
Stem cells are characterized as special human cells with the ability to develop into several different cell types, ranging from brain cells to muscle cells. In-depth research is now being done on various cell types, including mesenchymal stem cells, epithelial stem cells, resident tissue stem cells, embryonic stem cells, hematopoietic stem cells, as well as adipose-derived stem cells.
Regenerative medicine helps produce functional, living tissues to repair aged or diseased tissue; and is therefore utilized in the treatment of cardiovascular, orthopedic, neural, and autoimmune conditions. Regenerative medicine formerly included bioabsorbable scaffolds as well as other biochemical materials. Stem cell technology is also venturing into the avenue of regenerative medicine, as embryonic stem cells possess the potential to differentiate into and subsequently regenerate all kinds of tissues. As a result, the increasing demand for stem cells in regenerative medicine is anticipated to propel the global stem cell market growth.
REGIONAL INSIGHTS
The global stem cell market growth assessment comprises the evaluation of North America, the Asia-Pacific, Europe, and Rest of World. North America is projected to dominate the global market during the forecasted years on account of factors such as technological advancements in stem cell preservation and manufacturing, industry players’ substantial investments in R&D activities, and the surging public awareness of stem cell products’ therapeutic potential.
COMPETITIVE INSIGHTS
Over the forecast period, the intensity of industrial rivalry within the global stem cell market is expected to increase and remain high. Some of the top players operating in the global market are Corning Inc, GE Healthcare, Merck KGaA (Sigma Aldrich), etc.
Our report offerings include:
• Explore key findings of the overall market
• Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
• Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
• Market Segmentation cater to a thorough assessment of key segments with their market estimations
• Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
• Key analytics: Porter’s Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
• Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
• Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments
- 1. Research Scope & Methodology
- 1.1. Study Objectives
- 1.2. Scope Of Study
- 1.3. Methodology
- 1.4. Assumptions & Limitations
- 2. Executive Summary
- 2.1. Market Size & Estimates
- 2.2. Market Overview
- 3. Market Dynamics
- 3.1. Key Drivers
- 3.1.1. Surging Demand For Stem Cells In Regenerative Medicine
- 3.1.2. Growing R&D Investments In Stem Cell Therapies & Research
- 3.1.3. Rising Awareness About Umbilical Cord Stem Cells
- 3.1.4. Reduced Risk Of Tissue Rejection In Transplants
- 3.2. Key Restraints
- 3.2.1. Absence Of A Well-defined Regulatory Framework For Stem Cell Therapy
- 3.2.2. High Costs Associated With Stem Cell Procedures
- 3.2.3. Ethical Issues And Social Complexities
- 3.2.4. Less Responsiveness In Developed Economies
- 4. Key Analytics
- 4.1. Impact Of Covid-19 On Stem Cell Market
- 4.2. Key Market Trends
- 4.3. Porter’s Five Forces Analysis
- 4.3.1. Buyers Power
- 4.3.2. Suppliers Power
- 4.3.3. Substitution
- 4.3.4. New Entrants
- 4.3.5. Industry Rivalry
- 4.4. Opportunity Matrix
- 4.5. Vendor Landscape
- 4.6. Value Chain Analysis
- 4.7. Key Buying Criteria
- 4.7.1. Price
- 4.7.2. Efficacy
- 4.7.3. Application And Effectiveness
- 4.7.4. Accuracy
- 4.8. Regulatory Framework
- 5. Market By Therapeutic Application
- 5.1. Orthopedic Treatments
- 5.2. Injuries & Wounds
- 5.3. Oncology Disorders
- 5.4. Cardiovascular Disorders
- 5.5. Neurological Disorders
- 5.6. Diabetes
- 5.7. Other Therapeutic Applications
- 6. Market By Product
- 6.1. Adult Stem Cell
- 6.1.1. Hematopoietic Stem Cell
- 6.1.2. Neural Stem Cell
- 6.1.3. Umbilical Cord Stem Cell
- 6.1.4. Mesenchymal Stem Cell
- 6.1.5. Dental Stem Cell
- 6.2. Human Embryonic Stem Cell
- 6.3. Pluripotent
- 6.4. Mouse/Rat Neural
- 7. Market By Technology
- 7.1. Cell Acquisition
- 7.1.1. Bone Marrow Harvest
- 7.1.2. Umbilical Cord
- 7.1.3. Apheresis
- 7.2. Cell Production
- 7.2.1. Therapeutic Cloning
- 7.2.2. In Vitro Fertilization (Ivf)
- 7.2.3. Cell Culture
- 7.2.4. Isolation
- 7.3. Cryopreservation
- 7.4. Expansion & Sub-culture
- 8. Market By Application
- 8.1. Regenerative Medicine
- 8.2. Drug Discovery And Development
- 9. Market By Treatment Type
- 9.1. Allogeneic Stem Cell Therapy
- 9.2. Autologic Stem Cell Therapy
- 9.3. Syngeneic Stem Cell Therapy
- 10. Geographical Analysis
- 10.1. North America
- 10.1.1. Market Size & Estimates
- 10.1.2. Key Growth Enablers
- 10.1.3. Key Challenges
- 10.1.4. Key Players
- 10.1.5. Country Analysis
- 10.1.5.1. United States
- 10.1.5.2. Canada
- 10.2. Europe
- 10.2.1. Market Size & Estimates
- 10.2.2. Key Growth Enablers
- 10.2.3. Key Challenges
- 10.2.4. Key Players
- 10.2.5. Country Analysis
- 10.2.5.1. United Kingdom
- 10.2.5.2. Germany
- 10.2.5.3. France
- 10.2.5.4. Italy
- 10.2.5.5. Belgium
- 10.2.5.6. Poland
- 10.2.5.7. Rest Of Europe
- 10.3. Asia-pacific
- 10.3.1. Market Estimates & Sizes
- 10.3.2. Key Growth Enablers
- 10.3.3. Key Challenges
- 10.3.4. Key Players
- 10.3.5. Country Analysis
- 10.3.5.1. China
- 10.3.5.2. Japan
- 10.3.5.3. India
- 10.3.5.4. Australia & New Zealand
- 10.3.5.5. South Korea
- 10.3.5.6. Thailand
- 10.3.5.7. Indonesia
- 10.3.5.8. Vietnam
- 10.3.5.9. Rest Of Asia-pacific
- 10.4. Rest Of World
- 10.4.1. Market Estimates & Sizes
- 10.4.2. Key Growth Enablers
- 10.4.3. Key Challenges
- 10.4.4. Key Players
- 10.4.5. Regional Analysis
- 10.4.5.1. Latin America
- 10.4.5.2. Middle East & Africa
- 11. Competitive Landscape
- 11.1. Key Strategic Developments
- 11.1.1. Acquisitions
- 11.1.2. Partnerships
- 11.2. Company Profiles
- 11.2.1. Allcells Llc
- 11.2.2. Becton, Dickinson And Company (Bd)
- 11.2.3. Corning Inc
- 11.2.4. Ge Healthcare
- 11.2.5. International Stem Cell Corporation
- 11.2.6. Lorem Cytori Inc
- 11.2.7. Merck Kgaa (Sigma Aldrich)
- 11.2.8. Miltenyi Biotec
- 11.2.9. Pluri Inc
- 11.2.10. Qiagen
- 11.2.11. Smith+Nephew Plc
- 11.2.12. Stemcell Technologies Inc
- 11.2.13. Stryker Corporation
- 11.2.14. Takara Holdings Inc
- 11.2.15. Thermo Fisher Scientific Inc
Research Assistance
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook